Jim Cramer Says This Stock Is ‘Too Risky’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Cadre Holdings Inc (NYSE: CDRE) as it "makes things, does stuff, sells at a profit, gives you money back."
Morgan Stanley Maintains Underweight on Consolidated Edison, Raises Price Target to $76
Morgan Stanley analyst David Arcaro maintains Consolidated Edison (NYSE:ED) with a Underweight and raises the price target from $71 to $76.
Why Nio Stock Is Rising Today
NIO Inc (NYSE: NIO) shares are trading higher Friday after the company provided a delivery update for June, as well as the second quarter.
GM Says Sales To Commercial, Government And Rental Fleets Grew 29% YoY; Says Saw ‘Significant pent-up demand for GM vehicles amid low inventories’
https://investor.gm.com/news-releases/news-release-details/gm-continued-gain-us-market-share-and-extended-its-truck
GM Releases PR On Business Update
https://investor.gm.com/news-releases/news-release-details/gm-continued-gain-us-market-share-and-extended-its-truck
SPAC Northern Lights Amends Unit Purchase Agreement To Extend Outside Date
Northern Lights Acquisition Corp.
Goldman Sachs Maintains Neutral on RH, Lowers Price Target to $224
Goldman Sachs analyst Kate McShane maintains RH (NYSE:RH) with a Neutral and lowers the price target from $262 to $224.
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Here's a roundup of top developments in the biotech space over the last 24 hours: